We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Oncotherapy Plc | LSE:AVO | London | Ordinary Share | GB00BD6SX109 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.925 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -29.49M | -0.0549 | -0.35 | 10.32M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2016 10:14 | Just topped up.Still like the long term story. Things will turn once the next positive testing results are released. | seans66 | |
28/11/2016 09:47 | What we really need from the company right now is a statement clarifying the situation with Sinophi, and explaining whether the MOU between Sinophi and Hitachi has any effect on the relationship between AVO and Sinophi. | vatnabrekk | |
28/11/2016 09:31 | If you do not see Directors buying at these levels the I am afraid the game is up. | pyglet | |
28/11/2016 09:06 | lol. Always late to the party! | waterloo01 | |
28/11/2016 08:56 | Amusing and very sad thing about this board is the number of company supporters who stick up for the company.Somehow not realising that if their positive views had any grounding in reality the company itself would happily be trumpeting the good news.I see Waterloo is gloating: he was very late to the party re Harley St: long after I'd uncovered the gaping wound (just saying!!). | igbertsponk | |
28/11/2016 08:49 | Actually I pointed out both about Evans having left the company and the issues with Harley St both before TW did. (and both long before the company fessed up). Just saying. All it took was actually looking at the planning application and Evans own wiki page. | waterloo01 | |
27/11/2016 20:59 | TW will be seen to have got quite a lot wrong. But haho that's how he works. Never ever held accountable for his words. | john henry | |
27/11/2016 17:21 | Costax, it's not AVO that has an agreement with Hitachi, it is Sinophi. | vatnabrekk | |
27/11/2016 17:12 | Things are getting wrong here,might go under 50 | costax1654x | |
27/11/2016 17:11 | Avo have an agreement with Hitachi as well another proton provider | costax1654x | |
27/11/2016 16:56 | JHI suggest you take off your rose tinted specs for a while, get some honest answers to the questions that TW has raised from the BoD and only then decide to either put them back on or not.Regards | pyglet | |
27/11/2016 16:30 | I expect HS to be operational in 18 months | john henry | |
27/11/2016 16:28 | Waterloo what do you think the prototype is to be used for ??? | john henry | |
27/11/2016 15:55 | Whatever happens with AVO share price over the next weeks and I suspect it will rally, before it falls back again on (token) directors buys. I suspect not everything is quite out in the open as yet (and that's outside of the Evans issue/lost orders/who knew what when etc.) Harley St will be 2 years + to open once building actually starts, and I have some doubts that it will as I would have thought De Walden will be very nervous of going ahead given what's happened recently. Further basing the strategy on Harley st being the showcase on which 'orders' are based is hugely risky and ultimately flawed. Orders are already walking. IMO, Once proved up (tested fully) they should get the machine installed in an existing facility and use that as the test bed. That is the only way to get orders moving and justify the Thales investment (which is all upfront) OR the should sell the IP to a bigger, established player. They could always to it as a partial JV and the 'boys' can keep most of their jobs. | waterloo01 | |
27/11/2016 08:22 | Gibson, I guess in June this year things did remain on track for 2017 that's 6-18 months. I guess they hadn't concluded then that planning consent would take 5 months. Add the delayed planning and timescales become 2018 as per RNS | john henry | |
27/11/2016 03:09 | John Henry, there is nothing wrong with my research. The June half year results stated that there would be 2 treatment rooms, but also that the "progress for the new facility remains on track". Even the investor overview on the AVO site states that 2017 is still their target. That is why I say that their targets will not hold water with the market and the only thing that I can see taking us back above 100p is news confirming successful completion of testing. I'm hoping that is not too far off. | glibgibon | |
25/11/2016 15:55 | Would appear 100k was purchased around 14.42 @78p Directors buy imho | john henry | |
25/11/2016 15:36 | If I was a shareholder I'd be round at the HQ now sticking my boots where the sun don't shine. The Directors would need an MRI scan to find my size 9s. | igbertsponk | |
25/11/2016 15:28 | Calm down Igbert, you've made your point! Well done for calling this right but there's no need to stick the boot in! | no excuses | |
25/11/2016 15:28 | Have an average here of 75p happy to hold for 2-3 years | john henry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions